Category Archives: Vancouver

Why is Precision Nanosystems Inc. in the local (Vancouver, Canada) newspaper?

Usually when a company is featured in a news item, there’s some reason why it’s considered newsworthy. Even after reading the article twice, I still don’t see what makes the Precision Nanosystems Inc. (PNI) newsworthy.

Kevin Griffin’s Jan. 17, 2021 article about Vancouver area Precision Nanosystems Inc. (PNI) for The Province is interesting for anyone who’s looking for information about members of the local biotechnology and/or nanomedicine community (Note: Links have been removed),

A Vancouver nanomedicine company is part of a team using new genetic technology to develop a COVID-19 vaccine.

Precision NanoSystems Incorporated is working on a vaccine in the same class the ones made by Pfizer-BioNTech and Moderna, the only two COVID-19 vaccines approved by Health Canada.

PNI’s vaccine is based on a new kind of technology called mRNA which stands for messenger ribonucleic acid. The mRNA class of vaccines carry genetic instructions to make proteins that trigger the body’s immune system. Once a body has antibodies, it can fight off a real infection when it comes in contact with SARS-CoV-2, the name of the virus that causes COVID-19.

James Taylor, CEO of Precision NanoSystems, said the “revolutionary technology is having an impact not only on COVID-19 pandemic but also the treatment of other diseases.

The federal government has invested $18.2 million in PNI to carry its vaccine candidate through pre-clinical studies and clinical trails.

Ottawa has also invested another $173 million in Medicago, a Quebec-city based company which is developing a virus-like particle vaccine on a plant-based platform and building a large-scale vaccine and antibody production facility. The federal government has an agreement with Medicago to buy up to 76 million doses (enough for 38 million people) of its COVID-19 vaccine.

PNI’s vaccine, which the company is developing with other collaborators, is still at an early, pre-clinical stage.

Taylor is one of the co-founders of PNI along with Euan Ramsay, the company’s chief commercial officer.

The scientific co-founders of PNI are physicist Carl Hansen [emphasis mine] and Pieter Cullis. Cullis is also board chairman and scientific adviser at Acuitas Therapeutics [emphasis mine], the UBC biotechnology company that developed the delivery system for the Pfizer-BioNTech COVID-19 vaccine.

PNI, founded in 2010 as a spin-off from UBC [University of British Columbia], focuses on developing technology and expertise in genetic medicine to treat a wide range of infectious and rare diseases and cancers.

What has been described as PNI’s flagship product is a NanoAssemblr Benchtop Instrument, which allows scientists to develop nanomedicines for testing.

It’s informational but none of this is new, if you’ve been following developments in the COVID-19 vaccine story or local biotechnology scene. The $18.2 million federal government investment was announced in the company’s latest press release dated October 23, 2020. Not exactly fresh news.

One possibility is that the company is trying to generate publicity prior to a big announcement. As to why a reporter would produce this profile, perhaps he was promised an exclusive?

Acuitas Therapeutics, which I highlighted in the excerpt from Griffin’s story, has been featured here before in a November 12, 2020 posting about lipid nanoparticles and their role in the development of the Pfizer-BioNTech COVID-19 vaccine.

Curiously (or not), Griffin didn’t mention Vancouver’s biggest ‘COVID-19 star’, AbCellera. You can find out more about that company in my December 30, 2020 posting titled, Avo Media, Science Telephone, and a Canadian COVID-19 billionaire scientist, which features a link to a video about AbCellera’s work (scroll down about 60% of the way to the subsection titled: Avo Media, The Tyee, and Science Telephone, second paragraph).

The Canadian COVID-19 billionaire scientist? That would be Carl Hansen, Chief Executive Officer and co-founder of AbCellera and co-founder of PNI. it’s such a small world sometimes.

Avo Media, Science Telephone, and a Canadian COVID-19 billionaire scientist

I’ll start off with the COVID-19 billionaire since I imagine that excites the most interest.

AbCellera billionaire

No less an authority than the business magazine Forbes has produced a list of COVID-19 billionaires in its December 23, 2020 article (Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020) by Giacomo Tognini (Note: Links have been removed),

Nearly a year after the first case of Covid-19 was reported in the Chinese city of Wuhan in December 2019, the world could be nearing the beginning of the end of a pandemic that has killed more than 1.7 million people. Vaccination for Covid-19 is underway in the United States and the United Kingdom, and promising antibody treatments could help doctors fight back against the disease more effectively. Tied to those breakthroughs: a host of new billionaires who have emerged in 2020, their fortunes propelled by a stock market surge as investors flocked to companies involved in the development of vaccines, treatments, medical devices and everything in between.

Altogether, Forbes found 50 new billionaires in the healthcare sector in 2020. …

Carl Hansen

Net worth: $2.9 billion

Citizenship: Canada

Source of wealth: AbCellera

Hansen is the CEO and cofounder of Vancouver-based AbCellera, a biotech firm that uses artificial intelligence and machine learning to identify the most promising antibody treatments for diseases. He founded the company in 2012. Until 2019 he also worked as a professor at the University of British Columbia, but shifted to focus full-time on AbCellera. That decision seems to have paid off, and Hansen’s 23% stake earned him a spot in the billionaire club after AbCellera’s successful listing on the Nasdaq on December 11. The U.S. government has ordered 300,000 doses of bamlanivimab, an antibody AbCellera discovered in partnership with Eli Lilly that received FDA approval as a Covid-19 treatment in November [2020].

Hansen was a professor at the University of British Columbia (UBC) where he founded AbCellera. From https://innovation.ubc.ca/about/news/spin-company-abcelleras-antibody-discovery-leads-covid-19-treatment (Note: A link has been removed),

AbCellera, a local biotechnology company founded at UBC, has developed a method that can search immune responses more deeply than any other technology. Using a microfluidic technology developed at the Michael Smith Laboratories, advanced immunology, protein chemistry, performance computing, and machine learning, AbCellera is changing the game for antibody therapeutics.

I believe a great deal of research that is commercialized was initially funded by taxpayers and I cannot recall any entrepreneurs here in Canada or elsewhere acknowledging that help in a big way. Should you be able to remember any comments of that type, please do let me know in the Comments.

Just prior to this financial bonanza, AbCellera was touting two new board members, John Montalbano on Nov. 18, 2020 and Peter Thiel on Nov. 19, 2020.

Here’s a bit about Mr. Montalbano from a Nov. 18, 2020 AbCellera news release (Note: A link has been removed),

November 18, 2020 – AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, today announced the appointment of John Montalbano to its Board of Directors. Mr. Montalbano will serve as the Chair of the Audit Committee of the Board of Directors.

Mr. Montalbano is Principal of Tower Beach Capital Ltd. and serves on the boards of the Canada Pension Plan Investment Board, Aritzia Inc., and the Asia Pacific Foundation of Canada. His previous appointments include the former Vice Chair of RBC Wealth Management and CEO of RBC Global Asset Management (RBC GAM). When Mr. Montalbano retired as CEO of RBC GAM in 2015, it was among the largest 50 asset managers worldwide with $370 billion under management and offices in Canada, the United States, the United Kingdom, and Hong Kong.

Montalbano has been on this blog before in a Nov. 4, 2015 posting. If you scroll down to the subsection “Justin Trudeau and his British Columbia connection,” you’ll see mention of Montalbano’s unexpected exit as member and chair of UBC’s board of governors.

The next board member to hop on the proverbial path to riches was announced in a Nov. 19, 2020 AbCellera news release,

AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, today announced the appointment of Peter Thiel to its Board of Directors.

“Peter has been a valued AbCellera investor and brings deep experience in scaling global technology companies,” said Carl Hansen, Ph.D., CEO of AbCellera. “We share his optimistic vision for the future, faith in technological progress, and long-term view on company building. We’re excited to have him join our board and look forward to working with him over the coming years.”

Mr. Thiel is a technology entrepreneur, investor, and author. He was a co-founder and CEO of PayPal, a company that he took public before it was acquired by eBay for $1.5 billion in 2002. Mr. Thiel subsequently co-founded Palantir Technologies in 2004, where he continues to serve as Chairman. As a technology investor, Mr. Thiel made the first outside investment in Facebook, where he has served as a director since 2005, and provided early funding for LinkedIn, Yelp, and dozens of technology companies. He is a partner at Founders Fund, a Silicon Valley venture capital firm that has funded companies including SpaceX and Airbnb.

“AbCellera is executing a long-term plan to make biotech move faster. I am proud to help them as they raise our expectations of what’s possible,” said Mr. Thiel.

Some Canadian business journalists got very excited over Thiel’s involvement in particular. Perhaps they were anticipating this December 10, 2020 AbCellera news release announcing an initial public offering. Much money seems to have been made not least for Mr. Montalbano, Mr. Thiel, and Mr. Hansen.

As for Mr. Thiel and taxes, I don’t know for certain but can infer that he’s not a big fan from this portion of his Wikipedia entry,

Thiel is an ideological libertarian,[108] though more recently he has espoused support for national conservatism[109] and criticized libertarian attitudes towards free trade[110] and big tech.[109]

My understanding is that libertarians object to taxes and prefer as little government structure as possible.

In any event, it seems that COVID-19 has been quite the bonanza for some people. If you’re curious you can find out more about AbCellera here.

Onto Avo Media and how it has contributed to the AbCellera story.

Avo Media, The Tyee, and Science Telephone

Vancouver (Canada)-based Avo Media describes itself this way on its homepage,

We make documentary, educational, and branded content.

We specialize in communicating science and other complex concepts in a clear, engaging way.

I think that description boils down to videos and podcasts. There’s no mention of AbCellera as one of their clients but they do list The Tyee, which in a July 1, 2020 posting (The Vancouver Company Turning Blood into a COVID Treatment: A Tyee Video) by Mashal Butt hosts a video about AbCellera,

The world anxiously awaits a vaccine to end the pandemic. But having a treatment could save countless lives in the meantime.

This Tyee video explains how Vancouver biotech company AbCellera, with funding from the federal government, is racing to develop an antibody-based therapy treatment as quickly as possible.

Experts — immunologist Ralph Pantophlet at Simon Fraser University, and co-founder and COO of AbCellera Véronique Lecault — explain what an antibody treatment is and how it can protect us from COVID-19.

It is not a cure, but it can help save lives as we wait for the cure.

This video was made in partnership with Vancouver’s Avo Media team of Jesse Lupini, Koby Michaels and Lucas Kavanagh.

It’s a video with a good explanation of AbCellera’s research. Interestingly, the script notes that the Canadian federal government gave the company over $175M for its COVID-19 work.

Why The Tyee?

While Avo Media is a local company, I notice that Jessica Yingling is listed in the final credits for the video. Yingling founded Little Dog Communications, which is based in both California and Utah. If you read the AbCellera news releases, you’ll see that she’s the media contact.

Is there a more unlikely media outlet to feature a stock market star, which probably will be making billions of dollars from this pandemic, than The Tyee? Politically, its ideology could be described as the polar opposite to libertarian ideology.

I wonder what the thought process was for the media placement and how someone based in San Diego (check out her self description on this Twitter feed @jyingling) came up with the idea?

Science Telephone

Avo Media’s latest project seems to be a podcast series, Science Telephone (this link is to the Spotify platform). Here’s more about the series and the various platforms where episodes can be found (from the Avo Media, Our Work, Science Telephone webpage) ,

Science Telephone is a new podcast that tests how well the science holds up when comedians get their hands onto it

Laugh while you learn, as the classic game of telephone is repurposed for scientific research. Each episode, one scientist explains their research to a comedian, who then has to explain it to the next comedian, and so on until it’s almost unrecognizable. See what sticks and what changes, with a rotating cast of brilliant scientists and hysterical comedians.

See a preview of the show below, or visit www.sciencetelephone.com to subscribe or listen to past episodes.

Science telephone is available on all the usual podcast platforms, including Apple Podcasts and Google Podcasts

I have included the Science Telephone preview here,

As we move towards the end of this year and this pandemic, it’s time to enjoy a little science comedy.

“Imagine Van Gogh” in Vancouver (Canada) in 2021

Here’s a video about “Imagine Van Gogh,” coming soon to Vancouver, they hope, but which opened first in Montréal in December 2019 where almost 200,000 visited the exhibit before it moved to Winnipeg in March 2020 (Note: There is an advertisement before the Canadian Broadcasting Corporation’s (CBC) segment begins),

The Dec. 7, 2019 CBC news item (where video was embedded), provides more details about the exhibit experience (Note: A link has been removed),

Brushstrokes appear several feet wide, as more than 200 works, such as Starry Night and The Yellow House, are blown up and split into panels, giving visitors a 360-degree view of the paintings projected onto the walls and floor.

Annabelle Mauger, one of the artistic directors behind the exhibit, titled Imagine Van Gogh, says she tests this type of exhibition by seeing how her young children react to it.

“When I saw them just running [at] the image, running into the paintings, I think, this is the most fantastic thing I can do,” she told CBC News.

Mauger said she wanted to create a space where people could experience van Gogh’s art in ways traditional museums don’t allow. Classical music plays as you move around the warehouse space, where you can reach out and touch the simulated canvas or sit on the floor and watch the artwork swirl around you.

That feeling of being surrounded by the artwork is building on French photographer Albert Plécy‘s concept of “image totale,” which Maugler studied while in Provence, France at the Cathédrale d’images.

The Montreal showing of Imagine Van Gogh is its North American debut, with 40,000 tickets sold before it opened at the Arsenal Contemporary Art centre on Dec. 5.

But not everyone is a fan of such immersive art exhibitions, which seek to attract audiences to contemplate works of art by presenting them in an accessible format.

Artist Joseph Nechvatal, reviewing a similar digital art exhibition in Paris titled “Van Gogh, Starry Night,” decried it as “a nasty bit of metaphorical necrophilia” that degrades van Gogh’s daring works.

He called the show “one of the greatest banalizations of painting I have ever seen, matched only by van Gogh kitchen hand towels now being sold around town.”

In that exhibit, the paintings came to life through the use of computer-generated animation. But in Imagine Van Gogh, they retain their static quality as they’re projected on the walls, which lets the art express motion, Mauger says, while still remaining immobile.

“I don’t want the birds flying, you know,” said Mauger. “I don’t want to see the [self]-portrait of van Gogh smoking. No, for me, this is nonsense.”

Hrag Vartanian, the Canadian-raised editor-in-chief and co-founder of the influential art criticism website Hyperallergic, is more generous than Nechvatal in his assessment of the growing trend of immersive digital art shows.

“A lot of these artworks are sometimes disappointing when you’re in a museum and you realize it’s much smaller than you imagined it, or there’s a huge crowd and you don’t get a moment of contemplation you were hoping for,” he said in an interview from New York.

As for the proposed “Imagine Van Gogh” in Vancouver exhibition, Kenneth Chan reveals details about the plans in his Nov. 26, 2020 article for the Daily Hive,

A massive immersive digital art exhibition that blankets tall walls and floors with the projections of works by Vincent van Gogh is slated for Vancouver Convention Centre starting in February 2021.

Plans to bring the exhibition to Vancouver were announced today, but a specific start and end date has yet to be established. The exhibition will operate under the latest public health guidelines in BC.

The exhibition footprint inside the convention centre is 30,000 sq. ft. For context, the total amount of exhibition space at the Vancouver Art Gallery is about 41,000 sq. ft.

There has been immense interest with Imagine Van Gogh in Canada. It received nearly 200,000 visitors in Montreal before it closed in March, and almost 75,000 in Quebec City this past summer during the pandemic. Currently, the exhibition is underway in Winnipeg, and it has been extended to the end of December due to “incredible demand.”

The exhibition is in partnership with France-based Encore Productions and Paquin Entertainment Group and Tandem Expositions.

Organizers are asking interested parties to pre-register. I think they’re trying to gauge the level of interest Vancouverites have in this proposed exhibition. Organizers are offering some incentives to pre-register (from the Vancouver Imagine Van Gogh presale website),

Register now and be the first to know when tickets go on sale, and gain access to an exclusive presale to get tickets before they are available to the general public.

You will also be entered to

win one of three Premiere Packages

for you and three friends to attend the opening of the Imagine Van Gogh exhibit.
 
Additionally, you will receive other exclusive offers from our partners.

Imagine Van Gogh 2020. (Imagine Van Gogh [downloaded from https://dailyhive.com/vancouver/imagine-van-gogh-vancouver-2021]

If you need more inspiration, check out Chan’s Nov. 26, 2020 article where you will find many more images. Enjoy!

A Vancouver (Canada) connection to the Pfizer COVID-19 vaccine

Canada’s NanoMedicines Innovation Network (NMIN) must have been excited over the COVID-19 vaccine news (Pfizer Nov. 9, 2020 news release) since it’s a Canadian company (Acuitas Therapeutics) that is providing the means of delivering the vaccine once it enters the body.

Here’s the company’s president and CEO [chief executive officer], Dr. Thomas Madden explaining his company’s delivery system (from Acuitas’ news and events webpage),

For anyone who might find a textual description about the vaccine helpful, I have a Nov. 9, 2020 article by Adele Peters for Fast Company,

… a handful of small biotech companies began scrambling to develop vaccines using an as-yet-unproven technology platform that relies on something called messenger RNA [ribonucleic acid], usually shortened to mRNA …

Like other vaccines, mRNA vaccines work by training the immune system to recognize a threat like a virus and begin producing antibodies to protect itself. But while traditional vaccines often use inactivated doses of the organisms that cause disease, mRNA vaccines are designed to make the body produce those proteins itself. Messenger RNA—a molecule that contains instructions for cells to make DNA—is injected into cells. In the case of COVID-19, mRNA vaccines provide instructions for cells to start producing the “spike” protein of the new coronavirus, the protein that helps the virus get into cells. On its own, the spike protein isn’t harmful. But it triggers the immune system to begin a defensive response. As Bill Gates, who has supported companies like Moderna and BioNTech through the Gates Foundation, has described it, “you essentially turn your body into its own manufacturing unit.”

Amy Judd’s Nov. 9, 2020 article for Global news online explains (or you can just take another look at the video to refresh your memory) how the Acuitas technology fits into the vaccine picture,

Vancouver-based Acuitas Therapeutics, a biotechnology company, is playing a key role through a technology known as lipid nanoparticles, which deliver messenger RNA into cells.

“The technology we provide to our partners is lipid nanoparticles and BioNTech and Pfizer are developing a vaccine that’s using a messenger RNA that tells our cells how to make a protein that’s actually found in the COVID-19 virus,” Dr. Thomas Madden, president and CEO of Acuitas Therapeutics, told Global News Monday [Nov. 9, 2020].

“But the messenger RNA can’t work by itself, it needs a delivery technology to protect this after it’s administered and then to carry it into the cells where it can be expressed and give rise to an immune response.”

Madden said they like to think of the lipid nanoparticles as protective wrapping around a fragile glass ornament [emphasis mine] being shipped to your house online. That protective wrapping would then make sure the ornament made it to your house, through your front door, then unwrap itself and leave in your hallway, ready for you to come and grab it when you came home.

Acuitas Therapeutics employs 29 people and Madden said he believes everyone is feeling very proud of their work.

“Not many people are aware of the history of this technology and the fact that it originated in Vancouver,” he added.

“Dr. Pieter Cullis was one of the key scientists who brought together a team to develop this technology many, many years ago. UBC and Vancouver and companies associated with those scientists have been at the global centre of this technology for many years now.

“I think we’ve been looking for a light at the end of the tunnel for quite some time. I think everybody has been hoping that a vaccine would be able to provide the protection we need to move out of our current situation and I think this is now a confirmation that this hope wasn’t misplaced.”

Nanomedicine in Vancouver

For anyone who’s curious about the Canadian nanomedicine scene, you can find out more about it on Canada’s NanoMedicines Innovation Network (NMIN) website. They recently held a virtual event (Vancouver Nanomedicine Day) on Sept. 17, 2020 (see my Sept. 11, 2020 posting for details), which featured a presentation about Aquitas’ technology.

Happily, the organizers have posted videos for most of the sessions. Dr. Ying Tam of Acuitas made this presentation (about 22 mins. running time) “A Novel Vaccine Approach Using Messenger RNA‐Lipid Nanoparticles: Preclinical and Clinical Perspectives.” If you’re interested in that video or any of the others go to the NanoMedicines Innovation Network’s Nanomedicine Day 2020 webpage.

Acuitas Therapeutics can be found here.

Vancouver (Canada) Biennale and #ArtProject2020, a free virtual art & technology expo from November 11th to 15th, 2020

It’s a bit odd that the organizers for an event held in Canada would arrange to have Remembrance Day for the opening day and not make any acknowledgements. (For those not familiar with it, here’s more about Remembrance Day (Wikipedia entry) and there’s more here on the Canadian Broadcasting Corporation’s [CBC] Remembrance Day 2020 webpage and on this Nov. 10, 2020 ‘Here’s everything you need to know about the poppy’ article for the Daily Hive.)

The event description is quite exciting and the poster image is engaging, although ….

Courtesy: Vancouver Biennale

Did they intend for the blocks to the left and right (gateway to the bridge?) to look like someone holding both hands giving you the finger on each side? Now that I’ve seen it, I can’t ‘unsee’ it.

Moving on, there’s more information about the expo from a Nov. 9, 2020 Vancouver Biennale announcement (received via email),

The Vancouver Biennale announces a global invitation to #ArtProject2020, a free virtual art and technology expo about how the latest technologies are influencing the art world. The expo will run from November 11th to 15th and feature over 80 international speakers and 40 events offering accessible information and educational resources for digital art. Everyone with a personal or professional interest in art and technology, including curators, galleries, museums, artists, collectors, innovators, experience designers, and futurists will find the expo fascinating and is invited to register. Trilingual programming in English, Spanish, and Chinese will be available.

To reserve a free ticket and see the complete speaker list and schedule, visit www.artproject.io.

Curated by New York-based Colombian artist Jessica Angel, the expo will accompany the Vancouver Biennale’s first exhibition of tokenized art with new works by Jessica Angel, Dina Goldstein, Diana Thorneycroft, and Kristin McIver. Tokenized art is powered by blockchain technology and has redefined digital artwork ownership, allowing artists and collectors the benefit of true digital scarcity. The exhibition will be launched via the blockchain marketplace, Ephimera.

About the Expo

Panel Discussions, Artist Talks, Keynote Speakers: Innovators, curators, legal experts, and artists working at the leading edge of digital art will cover topics including What Is Cryptoart?, Finding Opportunity in the Digital, Women Leading the Art and Tech Movement, The Art of Immersion, Decentralising Power and Resources in the Art World, and Tools for Artists and Collectors. Speakers include The Whitney Museum, Victoria & Albert Museum, Christie’s, Foundation for Art and Blockchain, SuperRare, and Art in America.

Learning: Barrier-free educational workshops will teach participants about using open-source and accessible innovative tools to create, monetize, and collect digital art. Workshops are integrated with various blockchain projects to drive adoption through experience. Featured presenters include Ephimera, Status, and MakerDAO. Indigenous Matriachs 4 will present from the Immersive Knowledge Transfer series for XR media creators, artists, and storytellers from diverse cultural communities.

Activities: A Crypto-Art Puzzle will drop clues every day of the event, and the Digital Art Battle will challenge artists to draw live. This gamified experience will offer winners rewards in different tokens. Participates can also join the Rare AF team on a Virtual Gallery Tour through the Metaverse, where gallery owners will share the inspirations behind their virtual spaces.

Anchoring the virtual expo is a future physical installation by Jessica Angel. Cleverly titled Voxel Bridge, this public artwork will transform the area underneath Vancouver’s Cambie Street Bridge into a three-layered immersive experience to transport visitors between physical and digital worlds. Working with the vastness of the concrete bridge as first layer, Angel adds her site-specific installation as a second layer, and completes the experience with augmented reality enhancements over the real world as the third and final layer. The installation is slated for completion in Spring 2021 as part of the Vancouver Biennale Exhibition.

“I never want to see the Biennale stuck in the past, presenting only static sculpture in an ever-changing world. We work with what comes next, the yet unknown, and we want to go where the future is heading and where public art has, perhaps, always been going. I am excited for this expo and the next chapter of the Biennale.”  – Barrie Mowatt, Founder & Artistic Director of Vancouver Biennale

“Art is a mobilizing force with the power to bridge seemingly dissimilar worlds, and Voxel Bridge exhibits this capacity. This expo transcends the enjoyment of art into a unifying and experimenting effort, that enables blockchain technology and established art institutions to examine ways of interaction. Join us in the virtual public space, to learn, and to cultivate new forms of participation.”             – Jessica Angel, Artist

Do check the schedule: http://www.artproject.io/ (keep scrolling) and don’t forget it’s free in exchange for your registration information. Enjoy!

D-Wave’s new Advantage quantum computer

Thanks to Bob Yirka’s September 30, 2020 article for phys.org there’s an announcement about D-Wave Systems’ latest quantum computer and an explanation of how D-Wave’s quantum computer differs from other quantum computers. Here’s the explanation (Note: Links have been removed),

Over the past several years, several companies have dedicated resources to the development of a true quantum computer that can tackle problems conventional computers cannot handle. Progress on developing such computers has been slow, however, especially when compared with the early development of the conventional computer. As part of the research effort, companies have taken different approaches. Google and IBM, for example, are working on gate-model quantum computer technology, in which qubits are modified as an algorithm is executed. D-Wave, in sharp contrast, has been focused on developing so-called annealer technology, in which qubits are cooled during execution of an algorithm, which allows for passively changing their value.

Comparing the two is next to impossible because of their functional differences. Thus, using 5,000 qubits in the Advantage system does not necessarily mean that it is any more useful than the 100-qubit systems currently being tested by IBM or Google. Still, the announcement suggests that businesses are ready to start taking advantage of the increased capabilities of quantum systems. D-Wave notes that several customers are already using their system for a wide range of applications. Menten AI, for example, has used the system to design new proteins; grocery chain Save-On-Foods has been using it to optimize business operations; Accenture has been using it to develop business applications; Volkswagen has used the system to develop a more efficient car painting system.

Here’s the company’s Sept. 29, 2020 video announcement,

For those who might like some text, there’s a Sept. 29, 2020 D-Wave Systems press release (Note: Links have been removed; this is long),

D-Wave Systems Inc., the leader in quantum computing systems, software, and services, today [Sept. 29, 2020] announced the general availability of its next-generation quantum computing platform, incorporating new hardware, software, and tools to enable and accelerate the delivery of in-production quantum computing applications. Available today in the Leap™ quantum cloud service, the platform includes the Advantage™ quantum system, with more than 5000 qubits and 15-way qubit connectivity, in addition to an expanded hybrid solver service that can run problems with up to one million variables. The combination of the computing power of Advantage and the scale to address real-world problems with the hybrid solver service in Leap enables businesses to run performant, real-time, hybrid quantum applications for the first time.

As part of its commitment to enabling businesses to build in-production quantum applications, the company announced D-Wave Launch™, a jump-start program for businesses who want to get started building hybrid quantum applications today but may need additional support. Bringing together a team of applications experts and a robust partner community, the D-Wave Launch program provides support to help identify the best applications and to translate businesses’ problems into hybrid quantum applications. The extra support helps customers accelerate designing, building, and running their most important and complex applications, while delivering quantum acceleration and performance.

The company also announced a new hybrid solver. The discrete quadratic model (DQM) solver gives developers and businesses the ability to apply the benefits of hybrid quantum computing to new problem classes. Instead of accepting problems with only binary variables (0 or 1), the DQM solver uses other variable sets (e.g. integers from 1 to 500, or red, yellow, and blue), expanding the types of problems that can run on the quantum computer. The DQM solver will be generally available on October 8 [2020].

With support for new solvers and larger problem sizes backed by the Advantage system, customers and partners like Menten AI, Save-On-Foods, Accenture, and Volkswagen are building and running hybrid quantum applications that create solutions with business value today.

  • Protein design pioneer Menten AI has developed the first process using hybrid quantum programs to determine protein structure for de novo protein design with very encouraging results often outperforming classical solvers. Menten AI’s unique protein designs have been computationally validated, chemically synthesized, and are being advanced to live-virus testing against COVID-19.
  • Western Canadian grocery retailer Save-On-Foods is using hybrid quantum algorithms to bring grocery optimization solutions to their business, with pilot tests underway in-store. The company has been able to reduce the time an important optimization task takes from 25 hours to a mere 2 minutes of calculations each week. Even more important than the reduction in time is the ability to optimize performance across and between a significant number of business parameters in a way that is challenging using traditional methods.
  • Accenture, a leading global professional services company, is exploring quantum, quantum-inspired, and hybrid solutions to develop applications across industries. Accenture recently conducted a series of business experiments with a banking client to pilot quantum applications for currency arbitrage, credit scoring, and trading optimization, successfully mapping computationally challenging business problems to quantum formulations, enabling quantum readiness.
  • Volkswagen, an early adopter of D-Wave’s annealing quantum computer, has expanded its quantum use cases with the hybrid solver service to build a paint shop scheduling application. The algorithm is designed to optimize the order in which cars are being painted. By using the hybrid solver service, the number of color switches will be reduced significantly, leading to performance improvements.

The Advantage quantum computer and the Leap quantum cloud service include:

  • New Topology: The topology in Advantage makes it the most connected of any commercial quantum system in the world. In the D-Wave 2000Q™ system, qubits may connect to 6 other qubits. In the new Advantage system, each qubit may connect to 15 other qubits. With two-and-a-half times more connectivity, Advantage enables the embedding of larger problems with fewer physical qubits compared to using the D-Wave 2000Q system. The D-Wave Ocean™ software development kit (SDK) includes tools for using the new topology. Information on the topology in Advantage can be found in this white paper, and a getting started video on how to use the new topology can be found here.
  • Increased Qubit Count: With more than 5000 qubits, Advantage more than doubles the qubit count of the D-Wave 2000Q system. More qubits and richer connectivity provide quantum programmers access to a larger, denser, and more powerful graph for building commercial quantum applications.
  • Greater Performance & Problem Size: With up to one million variables, the hybrid solver service in Leap allows businesses to run large-scale, business-critical problems. This, coupled with the new topology and more than 5000 qubits in the Advantage system, expands the complexity and more than doubles the size of problems that can run directly on the quantum processing unit (QPU). In fact, the hybrid solver outperformed or matched the best of 27 classical optimization solvers on 87% of 45 application-relevant inputs tested in MQLib. Additionally, greater connectivity of the QPU allows for more compact embeddings of complex problems. Advantage can find optimal solutions 10 to 30 times faster in some cases, and can find better quality solutions up to 64% percent of the time, when compared to the D-Wave 2000Q LN QPU.
  • Expansion of Hybrid Software & Tools in Leap: Further investments in the hybrid solver service, new solver classes, ease-of-use, automation, and new tools provide an even more powerful hybrid rapid development environment in Python for business-scale problems.
  • Flexible Access: Advantage, the expanded hybrid solver service, and the upcoming DQM solver are available in the Leap quantum cloud service. All current Leap customers get immediate access with no additional charge, and new customers will benefit from all the new and existing capabilities in Leap. This means that developers and businesses can get started today building in-production hybrid quantum applications. Flexible purchase plans allow developers and forward-thinking businesses to access the D-Wave quantum system in the way that works for them and their business. 
  • Ongoing Releases: D-Wave continues to bring innovations to market with additional hybrid solvers, QPUs, and software updates through the cloud. Interested users and customers can get started today with Advantage and the hybrid solver service, and will benefit from new components of the platform through Leap as they become available.

“Today’s general availability of Advantage delivers the first quantum system built specifically for business, and marks the expansion into production scale commercial applications and new problem types with our hybrid solver services. In combination with our new jump-start program to get customers started, this launch continues what we’ve known at D-Wave for a long time: it’s not about hype, it’s about scaling, and delivering systems that provide real business value on real business applications,” said Alan Baratz, CEO, D-Wave. “We also continue to invest in the science of building quantum systems. Advantage was completely re-engineered from the ground up. We’ll take what we’ve learned about connectivity and scale and continue to push the limits of innovation for the next generations of our quantum computers. I’m incredibly proud of the team that has brought us here and the customers and partners who have collaborated with us to build hundreds of early applications and who now are putting applications into production.”

“We are using quantum to design proteins today. Using hybrid quantum applications, we’re able to solve astronomical protein design problems that help us create new protein structures,” said Hans Melo, Co-founder and CEO, Menten AI. “We’ve seen extremely encouraging results with hybrid quantum procedures often finding better solutions than competing classical solvers for de novo protein design. This means we can create better proteins and ultimately enable new drug discoveries.”

“At Save-On-Foods, we have been committed to bringing innovation to our customers for more than 105 years. To that end, we are always looking for new and creative ways to solve problems, especially in an environment that has gotten increasingly complex,” said Andrew Donaher, Vice President, Digital & Analytics at Save-On-Foods. “We’re new to quantum computing, and in a short period of time, we have seen excellent early results. In fact, the early results we see with Advantage and the hybrid solver service from D-Wave are encouraging enough that our goal is to turn our pilot into an in-production business application. Quantum is emerging as a potential competitive edge for our business.“

“Accenture is committed to helping our clients prepare for the arrival of mainstream quantum computing by exploring relevant use cases and conducting business experiments now,” said Marc Carrel-Billiard, Senior Managing Director and Technology Innovation Lead at Accenture. “We’ve been collaborating with D-Wave for several years and with early access to the Advantage system and hybrid solver service we’ve seen performance improvements and advancements in the platform that are important steps for helping to make quantum a reality for clients across industries, creating new sources of competitive advantage.”

“Embracing quantum computing is nothing new for Volkswagen. We were the first to run a hybrid quantum application in production in Lisbon last November with our bus routing application,” said Florian Neukart, Director of Advanced Technologies at Volkswagen Group of America. “At Volkswagen, we are focusing on building up a deep understanding of meaningful applications of quantum computing in a corporate context. The D-Wave system gives us the opportunity to address optimization tasks with a large number of variables at an impressive speed. With this we are taking a step further towards quantum applications that will be suitable for everyday business use.”

I found the description of D-Wave’s customers and how they’re using quantum computing to be quite interesting. For anyone curious about D-Wave Systems, you can find out more here. BTW, the company is located in metro Vancouver (Canada).

7th annual Vancouver Nanomedicine Day, Sept. 17, 2020

Like so many events these days (COVID-19 days), this event put on by Canada’s NanoMedicines Innovation Network (NMIN) will be held virtually. Here’s more from the ‘Virtual’ Vancouver Nanomedicine Day 2020 event page on the NMIN website,

This world-class symposium, the sixth event of its kind, will bring together a record number (1000+) of renowned Canadian and international experts from across the nanomedicines field to:

  • highlight the discoveries and innovations in nanomedicines that are contributing to global progress in acute, chronic and orphan disease treatment and management;
  • present up-to-date diagnostic and therapeutic  nanomedicine approaches to addressing the challenges of COVID-19; and
  • facilitate discussion among nanomedicine researchers and innovators and UBC and NMIN clinician-scientists, basic researchers, trainees, and research partners.

Since 2014, Vancouver Nanomedicine Day has advanced nanomedicine research, knowledge mobilization and commercialization in Canada by sharing high-impact findings and facilitating interaction—among researchers, postdoctoral fellows, graduate students, and life science and startup biotechnology companies—to catalyze research collaboration.

Here are a few highlights from the ‘Virtual’ Vancouver Nanomedicine Day 2020 event page,

  • An introduction to nanomedicines by Dr. Emmanuel Ho (University of Waterloo)
  • A keynote address by an iconic nanomedicine innovator: Dr. Robert Langer (MIT, Department of Chemical Engineering)
  • Invited talks by internationally renowned experts, including Dr. Vito Foderà (The University of Copenhagen, Denmark); Dr. Lucia Gemma Delogu (University of Padova, Italy); and Dr. Christine Allen (University of Toronto)
  • A virtual poster competition, with cash prizes for the top posters
  • A debate on whether “nanomedicines are still the next big thing” between Marcel Bally (proponent) and Kishor Wasan (opponent)

You can get the Program in PDF.

Registration is free. But you must Register.

Here’s the event poster,

[downloaded from https://www.nanomedicines.ca/nmd-2020/]

I have a few observations, First, Robert Langer is a big deal. Here are a few highlights from his Wikipedia entry (Note: Links have been removed),

Robert Samuel Langer, Jr. FREng[2] (born August 29, 1948) is an American chemical engineer, scientist, entrepreneur, inventor and one of the twelve Institute Professors at the Massachusetts Institute of Technology.[3]

Langer holds over 1,350 granted or pending patents.[3][29] He is one of the world’s most highly cited researchers, having authored nearly 1,500 scientific papers, and has participated in the founding of multiple technology companies.[30][31]

Langer is the youngest person in history (at 43) to be elected to all three American science academies: the National Academy of Sciences, the National Academy of Engineering and the Institute of Medicine. He was also elected as a charter member of National Academy of Inventors.[32] He was elected as an International Fellow[2] of the Royal Academy of Engineering[2] in 2010.

It’s all about commercializing the research—or is it?

(This second observation is a little more complicated and requires a little context.) The NMIN is one of Canada’s Networks of Centres of Excellence (who thought that name up? …sigh), from the NMIN About page,

NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

The NCEs seem to be firmly fixed on finding pathways to commercialization (from the NCE About page) Note: All is not as it seems,

Canada’s global economic competitiveness [emphasis mine] depends on making new discoveries and transforming them into products, services [emphasis mine] and processes that improve the lives of Canadians. To meet this challenge, the Networks of Centres of Excellence (NCE) offers a suite of programs that mobilize Canada’s best research, development and entrepreneurial [emphasis mine] expertise and focus it on specific issues and strategic areas.

NCE programs meet Canada’s needs to focus a critical mass of research resources on social and economic challenges, commercialize [emphasis mine] and apply more of its homegrown research breakthroughs, increase private-sector R&D, [emphasis mine] and train highly qualified people. As economic [emphasis mine] and social needs change, programs have evolved to address new challenges.

Interestingly, the NCE is being phased out,

As per the December 2018 NCE Program news, funding for the Networks of Centres of Excellence (NCE) Program will be gradually transferred to the New Frontiers in Research Fund (NFRF).

The new agency, NFRF, appears to have a completely different mandate, from the NFRF page on the Canada Research Coordinating Committee webspace,

The Canada Research Coordinating Committee designed the New Frontiers in Research Fund (NFRF) following a comprehensive national consultation, which involved Canadian researchers, research administrators, stakeholders and the public. NFRF is administered by the Tri-agency Institutional Programs Secretariat, which is housed within the Social Sciences and Humanities Research Council (SSHRC), on behalf of Canada’s three research granting agencies: the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council and SSHRC.

The fund will invest $275 million over the next 5 years beginning in fiscal 2018-19, and $65 million ongoing, to fund international, interdisciplinary, fast-breaking and high-risk research.

NFRF is composed of three streams to support groundbreaking research.

  • Exploration generates opportunities for Canada to build strength in high-risk, high-reward and interdisciplinary research;
  • Transformation provides large-scale support for Canada to build strength and leadership in interdisciplinary and transformative research; and
  • International enhances opportunities for Canadian researchers to participate in research with international partners.

As you can see there’s no reference to commercialization or economic challenges.

Personally

Here at last is the second observation, I find it hard to believe that the government of Canada has given up on the idea of commercializing research and increasing the country’s economic competitiveness through research. Certainly, Langer’s virtual appearance at Vancouver Nanomedicine Day 2020, suggests that at least some corners of the Canadian research establishment are remaining staunchly entrepreneurial.

After all, the only Canadian government ministry with science in its name is this one: Innovation, Science and Economic Development Canada (ISED), as of Sept. 11, 2020.. (The other ‘science’ ministries are Natural Resources Canada, Environment and Climate Change Canada, Fisheries and Oceans Canada, Health Canada, and Agriculture and Agri-Food Canada.) ISED is not exactly subtle. Intriguingly the latest review on the state of science and technology in Canada was released on April 10, 2018 (from the April 10, 2018 Council of Canadian Academies CCA] news release),

Canada remains strong in research output and impact, capacity for R&D and innovation at risk: New expert panel report

While Canada is a highly innovative country, with a robust research base and thriving communities of technology start-ups, significant barriers—such as a lack of managerial skills, the experience needed to scale-up companies, and foreign acquisition of high-tech firms—often prevent the translation of innovation into wealth creation.[emphasis mine] The result is a deficit of technology companies growing to scale in Canada, and a loss of associated economic and social benefits.This risks establishing a vicious cycle, where successful companies seek growth opportunities elsewhere due to a lack of critical skills and experience in Canada guiding companies through periods of rapid expansion.

According to the CCA’s [2018 report] Summary webpage, it was Innovation, Science and Economic Development Canada which requested the report. (I wrote up a two-part commentary under one of my favourite titles: “The Hedy Lamarr of international research: Canada’s Third assessment of The State of Science and Technology and Industrial Research and Development in Canada.” Part 1 and Part 2)

I will be fascinated to watch the NFRF and science commercialization situations as they develop.

In the meantime, you can sign up for free to attend the ‘Virtual’ Vancouver Nanomedicine Day 2020.

Bio and neuro inspiration at Metro Vancouver’s (Canada) 2020 Zero Waste Conference (ZWC)

For anyone not familiar with Metro Vancouver (and before I launch into the 2020 Zero Waste conference [ZWC] news and discuss why this year is particularly interesting [to me, anyway]), here’s a description from the Metro Vancouver About Us webpage,

Metro Vancouver is a federation of 21 municipalities [including Vancouver, Canada], one Electoral Area and one Treaty First Nation that collaboratively plans for and delivers regional-scale services. Its core services are drinking water, wastewater treatment and solid waste management. Metro Vancouver also regulates air quality, plans for urban growth, manages a regional parks system and provides affordable housing. The regional district is governed by a Board of Directors of elected officials from each local authority.

2020 Zero Waste Conference (ZWC) celebrates 10 years?

Apparently, the organizers are planning some limited in-person participation for the 2020 edition of the Zero Waste conference (from the Aug. 7, 2020 ZWC blog posting) Note: Pay special attention to the second sentence in the first paragraph,

For the past 10 years, Metro Vancouver’s annual Zero Waste Conference has been at the forefront of Canada’s journey into the circular economy. This year, we are pleased to keep the engagement going online and with an in-person option for a limited number of participants (more to come).

The 2020 Zero Waste Conference promises the same insightful programming we’ve provided over the past decade, but in a new, virtual format. For the first time, conference participants will be able to hear from and connect with the thought leaders, innovators and change agents working to advance waste prevention and the circular economy in Canada – all from the comfort of their own homes or offices.

The COVID-19 pandemic and ongoing public health response may have resulted in some near-term setbacks for the zero waste movement. However, as we work together to ‘Build Back Better,’ it is essential that we critically examine our society’s relationships with products, packaging and waste, and garner the courage to create systems and build infrastructure that will enable a transition to a circular and zero waste economy, creating solutions that combine economic opportunity with benefits to wider society and the environment.

We are living through an era of unprecedented change and transformation. How do we apply our creativity and knowledge to craft a future for Canada that embraces new materials, new ways of doing business and new policies that not only prevent waste and promote circularity, but that help us move toward a more sustainable, healthy and equitable future?

We look forward to highlighting some of the best ideas from the last 10 years and presenting pioneering solutions that take us to a future most of us have only begun to dare dream is possible.

I imagine the option for in-person participation is contingent on the COVID-19 situation in the province of British Columbia and, specifically, the Metro Vancouver region. At the time of this writing, the number of cases in the province are rising steadily, again.

As for the question mark in the head for this subsection, it’s unusual for an organization to not make a big fuss of their 10th annual [anything] leading me to wonder why?

Now, onto the item that sparked my interest in the 2020 ZWC.

Suzanne Lee and growing your clothes

Here’s the August 27, 2020 ZWC notice (received via email) announcing a speaker’s proposed new paradigm for fashion,

Growing a New Paradigm:
Biofabrication Pioneer Suzanne Lee at #ZWC20

The textiles & fashion industry is one of the biggest polluters on earth, accounting for a staggering amount of carbon emissions, water consumption and ocean microplastics.

But what if we could produce durable and beautiful clothes with far less pollution and waste, using the processes at the heart of life itself?

We are pleased to welcome Suzanne Lee, material innovator and founder of Biofabricate, as morning keynote for the “Next Generation Materials” session.

“Biofabrication” uses microscopic organisms to reinvent the way we make everything from clothes to couches to buildings, and holds the promise for radically cutting emissions and eliminating waste.

Join us at the 2020 Zero Waste Conference to hear how Suzanne Lee and her colleagues are using fungi, bacteria, yeast and algae to revolutionize the fashion world from the ground up.

As Suzanne Lee says,

“Once you realize that these materials are better for the planet, animals and us, why would we go back to the toxic, polluting materials of the past?”

Join us on Friday, November 13th for the next phase of Canada’s zero waste journey.

Registration is now open for the 2020 Zero Waste Conference

REGISTER NOW

I haven’t stumbled across Lee’s work in the last few years but between 2010 and 2014, I featured her work here three times:

You can find out more about Suzanne Lee and her work here (Note: This website seems to consist of a single page with links to other sites associated with Lee) and you can find out more about Lee’s latest company, Biofabricate here.

ZWC 2020 opening keynote address from a ‘neuro guy’

I’ve not come across Dr. Beau Lotto before but according to an August 18, 2020 posting on the ZWC blog, he’s giving the opening keynote address,

Embracing Uncertainty to Spark Innovation – ZWC20 Keynote Beau Lotto

We find ourselves amid uncertain times, and for those of us passionate about systems change and innovation, these are also times of great opportunity. But how exactly do we meet goals like advancing waste prevention and expanding the circular economy in the face of all this uncertainty?

To help answer that question, we’re pleased to introduce you to this year’s Zero Waste Conference opening keynote: Dr. Beau Lotto.

Frontiers in Science of Uncertainty

#ZWC20 Keynote Beau Lotto is no stranger to uncertainty – in fact, that is his main focus as a neuroscientist and entrepreneur.

Through his presentations (including three TED Talks), masterclasses and a proprietary form of consultancy build on “experiential experiments,” Dr. Lotto teaches organizations and individuals how to apply scientific truths about perception to adapt and thrive in an ever-changing world.

His work probes how the human mind deals with the unknown and reveals fascinating and actionable implications for creativity, courage, emotional well-being and social connections.

Unlocking Our Creativity

How do we use the upheaval represented by COVID-19 as an opportunity to build back a more equitable and sustainable future?

The key, as Dr. Lotto said in a recent podcast interview, is to embrace uncertainty:

““Uncertainty is the only place you can go if you’re ever going to see differently the only place you can go if you’re going to be creative.”

As a researcher well versed in the circular economy and the challenges associated with global systems change, Beau Lotto brings a deep understanding of the importance of risk-taking and innovation.

We are pleased to welcome Dr. Lotto to #ZWC20 to set the stage and inspire us to embrace uncertainty and to step forward toward the future we want to bring about.  

How we proceed as a region – indeed, as a province, a country and continent – to address issues affecting our economy, environment and social make-up depends on our collective ability to be creative, innovative, and on our willingness to protect and nurture our communities.

We hope you will join us in the next phase of Canada’s zero waste journey.

You can find out more about Dr. Beau Lotto here.

This advertising video is largely comprised of a number of clips from various talks. He’s a dynamic speaker as opposed to being a quiet speaker,

Interesting, eh?

You can find out more about Metro Vancouver’s 2020 Zero Waste Conference here.

Engineering and Geoscience Festival in Vancouver (Canada) on March 7, 2020

I was going to include event poster but I cannot figure out how to embed it here. For some reason the folks of the Vancouver Branch of Engineers and Geoscientists BC have made it difficult to do for someone as nontechnical as I am.

So, here’s the plain version (from the Vancouver Public Library Event page for the Engineering & Geoscience Festival on March 7, 2020),

EG-Fest: Engineering & Geoscience Festival

Saturday, March 7, 2020
10:00 am – 4:00 pm
Central Library [350 West Georgia St.]

Please join the Engineers & Geoscientists of BC Vancouver Branch and the Vancouver Public Library as we host this fantastic event to showcase engineering and geosciences.

See how the many facets of engineering and geoscience affect our everyday lives! Explore interactive exhibits and displays in celebration of National Engineering and Geoscience Month.

In Partnership with APEGBC Vancouver Branch.

APGEBC stands for Association of Professional Engineers and Geoscientists of British Columbia and they are sometimes referred to as Engineers and Geoscientists BC (see Wikipedia entry). They (APGEBC) too have an event page listing the event and giving a little more information about why they’re hosting it and what you might find should you attend,

EG-Fest is a 1-day trade show style event organized by engineering and geoscience professionals and companies, and takes place during National Engineering and Geoscience Month. This is a great opportunity for people in our community to see first-hand how the many facets of engineering and geoscience affect our everyday lives.

The main goal of EG-Fest is to extend public knowledge and appreciation of engineering and geoscience. Each year, several thousand people pass through the Vancouver Public Library promenade to visit the many booths, demonstrations, and exhibits, as well as to speak with the representatives to learn about our profession.

This event is part of National Engineering and Geoscience Month (NEGM); an annual celebration of engineering and geoscience across Canada. The goal of this event is to promote the awareness of the engineering and geoscience professions, showcase career choices, and the many ways in which engineering and geoscience relate to our everyday life.

Everyone is welcome to attend and we encourage you to bring your friends and family. We hope to see you there.

I hope the COVID-19 (coronavirus disease 2019) situation doesn’t affect attendance too much. For the curious, there’s a Canadian Broadcasting Corporation (CBC) radio article, 5 lessons about COVID-19 from doctor who led WHO [World Health Organization] mission to China, which includes helpful tips and information. The Scientist has gathered its latest coverage of the Coronavirus Outbreak here.

A Café Scientifique Vancouver (Canada) February 25, 2020 talk ‘ Invasive Species of the Lower Mainland 101’

From a February 22, 2020 Café Scientifque announcement (received via email),

Our next café will happen on Tuesday, February 25th, 2020 at 7:30pm in the back room at Yagger’s Downtown (433 W Pender). Our speaker for the evening will be marine biologist Dr. Nick Wong who is associated with the conservation of invasive species [sic].

TITLE OF PRESENTATION: Invasive Species of the Lower Mainland 101

BRIEF ABSTRACT OF WORK: The Invasive Species Council of BC (ISCBC) is a collaborative-based organization committed to reducing the spread and impacts of non-native species within BC.

My role focuses on educating and informing a diverse range of audiences on current and “watchlist” invasive species in British Columbia.

Nick will give details about the key invasives species in the lower mainland, describe some of the ISCBC programs and share things you can do to preserve BC’s amazing biodiversity.

BIO: Nick is the Research and Projects Coordinator with the Invasive Species Council of BC. He received his BSc from Western University [Ontario] and an MSc and PhD in Marine Ecology from the University of Auckland. Nick is passionate about teaching and creating engaging opportunities for people to learn and understand the role they can play in the prevention and mitigation of invasive species.

If the annual reports page is to be believed, the ISCBC has been around since 2006. Nope, I just looked at the 2006 report and the introduction states they were just starting their fourth year of existence at that time. Here’s the ISCBC website.

One final comment, it seems like there might have been a lost opportunity. The ISCBC would have been an interesting addition as a sponsor or partner to the Invasive Systems Festival organized by the Curiosity Collider folks. The festival was mentioned in my October 14, 2019 posting (scroll down about 60% of the way).